Adapting Gastrointestinal Cancer Care to the Latest Evidence in Biomarker-Informed Treatment Decision Making
Adapting Gastrointestinal Cancer Care to the Latest Evidence in Biomarker-Informed Treatment Decision Making is organized by Prime Education, LLC.
Release Date: February 17, 2023
Expiration Date: February 16, 2024
Description:
With new indications for immuno-oncology and targeted therapies, and associated biomarker testing requirements, the treatment landscape in gastrointestinal cancer continues to evolve rapidly. The symposium features:
• The latest updates on therapies and biomarker testing guidelines for advanced gastroesophageal and colon cancers
• Expert insights into optimally integrating novel therapies into practice
• The opportunity to test your skills with real-world case examples
• Strategies to recognize and manage adverse events of novel systemic therapies
Agenda:
• Biomarker Testing Guidelines and Associated Therapy Recommendations in Colon and Gastroesophageal Cancers
• Current Guidelines and Clinical Evidence for Selection and Sequencing of Systemic Therapies for Gastroesophageal Cancers
• Current Guidelines and Clinical Evidence for Selection and Sequencing of Systemic Therapies for Colon Cancer
• Recognizing and Managing Adverse Events of Novel Systemic Therapies
• Patient-Centered Multidisciplinary Care for Advanced GI Cancers
Learning Objectives:
• Evaluate current guideline recommendations on selecting, interpreting, and acting on the results of molecular biomarker testing, including patient-specific considerations in advanced GI cancers
• Apply updated guidelines and recent clinical trial data to the selection and sequencing of first- and later-line therapies in patients with advanced GI cancers
• Develop evidence-based strategies for monitoring and mitigating adverse events of novel therapies for treatment of GI cancers
• Employ interprofessional strategies to integrate the latest evidence in GI cancers into the clinical workflow